4 Stocks Pushing The Health Services Industry Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 9 points (-0.1%) at 14,437 as of Tuesday, March 12, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,094 issues advancing vs. 1,829 declining with 130 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Intuitive Surgical ( ISRG), down 1.0%, Baxter International ( BAX), down 0.8% and Edwards Life ( EW), down 0.5%. Top gainers within the industry include Life Technologies ( LIFE), up 2.3%, Aetna ( AET), up 1.5%, UnitedHealth Group ( UNH), up 1.2%, Smith & Nephew ( SNN), up 0.8% and WellPoint ( WLP), up 0.5%.

TheStreet Ratings group would like to highlight 4 stocks pushing the industry lower today:

4. Emeritus Corporation ( ESC) is one of the companies pushing the Health Services industry lower today. As of noon trading, Emeritus Corporation is down $2.21 (-7.2%) to $28.35 on heavy volume Thus far, 339,519 shares of Emeritus Corporation exchanged hands as compared to its average daily volume of 192,100 shares. The stock has ranged in price between $28.35-$30.27 after having opened the day at $30.27 as compared to the previous trading day's close of $30.56.

Emeritus Corporation operates senior living communities in the United States. The company's communities offer Alzheimer's and dementia care, independent living, assisted living, specialized memory care, and skilled nursing care services. Emeritus Corporation has a market cap of $1.4 billion and is part of the health care sector. Shares are up 23.1% year to date as of the close of trading on Monday. Currently there are 6 analysts that rate Emeritus Corporation a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Emeritus Corporation as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, disappointing return on equity and weak operating cash flow. Get the full Emeritus Corporation Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

3. As of noon trading, Mettler-Toledo International ( MTD) is down $2.22 (-1.0%) to $217.38 on light volume Thus far, 30,047 shares of Mettler-Toledo International exchanged hands as compared to its average daily volume of 165,800 shares. The stock has ranged in price between $217.11-$219.68 after having opened the day at $219.68 as compared to the previous trading day's close of $219.60.

Mettler-Toledo International Inc. supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. Mettler-Toledo International has a market cap of $6.6 billion and is part of the health care sector. The company has a P/E ratio of 23.9, above the S&P 500 P/E ratio of 17.7. Shares are up 13.6% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Mettler-Toledo International a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Mettler-Toledo International Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

2. As of noon trading, DaVita HealthCare Partners ( DVA) is down $0.84 (-0.7%) to $117.56 on average volume Thus far, 367,441 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 797,500 shares. The stock has ranged in price between $116.83-$118.20 after having opened the day at $118.20 as compared to the previous trading day's close of $118.40.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $12.5 billion and is part of the health care sector. The company has a P/E ratio of 21.7, above the S&P 500 P/E ratio of 17.7. Shares are up 7.1% year to date as of the close of trading on Monday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, increase in net income, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full DaVita HealthCare Partners Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

1. As of noon trading, Humana ( HUM) is down $0.51 (-0.8%) to $67.82 on average volume Thus far, 909,167 shares of Humana exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $67.60-$68.39 after having opened the day at $68.26 as compared to the previous trading day's close of $68.33.

Humana Inc. operates as a health care company that offers a range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Health and Well-Being Services. Humana has a market cap of $10.8 billion and is part of the health care sector. The company has a P/E ratio of 9.1, below the S&P 500 P/E ratio of 17.7. Shares are down 0.4% year to date as of the close of trading on Monday. Currently there are 15 analysts that rate Humana a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Humana Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers